Literature DB >> 2822384

Membrane-assisted molecular mechanism of neurokinin receptor subtype selection.

R Schwyzer1.   

Abstract

Based on the observed membrane structures of substance P, physalaemin, and eledoisin, preferred conformations, orientations and accumulations of 13 mammalian neurokinins and non-mammalian tachykinins were estimated and compared with pharmacologic and selective binding data taken from the literature. Principal site affinities and relative affinities supported the view that neurokinins bind to three principal mammalian sites: the NK-1 (preferring substance P), the NK-2 (preferring neurokinin A), and the NK-3 site (preferring neurokinin B). Strong hydrophobic membrane interaction of the C-terminal message segment as a perpendicularly oriented alpha-helical domain correlated with NK-1 selection. Electrostatic accumulation of the peptide at the anionic fixed charge layer of the membrane without hydrophobic interaction through a helix correlated with NK-2 preference. Electrostatic repulsion by the anionic fixed charge layer correlated with NK-3 selection. Thus, neurokinin receptor selection is guided by the same principles as opioid receptor selection. Membrane catalysis of specific agonist--receptor interactions may prove to be a quite general phenomenon, and the membrane structure of a peptide more important for its structure--activity relationship than its crystal structure or its mixture of conformers in solution or in vacuo.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822384      PMCID: PMC553626          DOI: 10.1002/j.1460-2075.1987.tb02498.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  31 in total

Review 1.  The alpha-helix as an electric macro-dipole.

Authors:  A Wada
Journal:  Adv Biophys       Date:  1976

Review 2.  Nonopioid neuropeptides in mammalian CNS.

Authors:  L L Iversen
Journal:  Annu Rev Pharmacol Toxicol       Date:  1983       Impact factor: 13.820

Review 3.  Substance P.

Authors:  L L Iversen
Journal:  Br Med Bull       Date:  1982-09       Impact factor: 4.291

4.  Opiate receptor subclasses differ in their conformational requirements.

Authors:  P W Schiller; J DiMaio
Journal:  Nature       Date:  1982-05-06       Impact factor: 49.962

5.  Parallel bioassay of physalaemin and kassinin, a tachykinin dodecapeptide from the skin of the African frog Kassina senegalensis.

Authors:  G F Erspamer; V Erspamer; D Piccinelli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-02       Impact factor: 3.000

6.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

7.  The possible existence of multiple receptors for substance P.

Authors:  C M Lee; L L Iversen; M R Hanley; B E Sandberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-03       Impact factor: 3.000

Review 8.  Structure and function in neuropeptides.

Authors:  R Schwyzer
Journal:  Proc R Soc Lond B Biol Sci       Date:  1980-10-29

Review 9.  Pharmacological receptors for substance P and neurokinins.

Authors:  D Regoli; G Drapeau; S Dion; P D'Orléans-Juste
Journal:  Life Sci       Date:  1987-01-12       Impact factor: 5.037

10.  The essential sequence of substance P for locomotion.

Authors:  K Treptow; R Morgenstern; P Oehme; M Bienert
Journal:  Pharmazie       Date:  1986-10       Impact factor: 1.267

View more
  18 in total

1.  The bacterial elicitor flagellin activates its receptor in tomato cells according to the address-message concept.

Authors:  T Meindl; T Boller; G Felix
Journal:  Plant Cell       Date:  2000-09       Impact factor: 11.277

2.  Solution structure of the tachykinin peptide eledoisin.

Authors:  R Christy Rani Grace; Indu R Chandrashekar; Sudha M Cowsik
Journal:  Biophys J       Date:  2003-01       Impact factor: 4.033

3.  Unraveling membrane-mediated substrate-transporter interactions.

Authors:  Anna Seelig
Journal:  Biophys J       Date:  2006-03-24       Impact factor: 4.033

4.  The micelle-associated 3D structures of Boc-Y(SO3)-Nle-G-W-Nle-D-2-phenylethylester (JMV-180) and CCK-8(s) share conformational elements of a calculated CCK1 receptor-bound model.

Authors:  Mohanraja Kumar; Joseph R Reeve; Weidong Hu; Laurence J Miller; David A Keire
Journal:  J Med Chem       Date:  2008-06-10       Impact factor: 7.446

5.  Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency.

Authors:  Paolo Ingallinella; Elisabetta Bianchi; Neal A Ladwa; Ying-Jie Wang; Renee Hrin; Maria Veneziano; Fabio Bonelli; Thomas J Ketas; John P Moore; Michael D Miller; Antonello Pessi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-18       Impact factor: 11.205

Review 6.  Subcellular targeting strategies for drug design and delivery.

Authors:  Lawrence Rajendran; Hans-Joachim Knölker; Kai Simons
Journal:  Nat Rev Drug Discov       Date:  2010-01       Impact factor: 84.694

7.  Insights into the Impact of a Membrane-Anchoring Moiety on the Biological Activities of Bivalent Compounds As Potential Neuroprotectants for Alzheimer's Disease.

Authors:  Liu He; Yuqi Jiang; Kai Liu; Victoria Gomez-Murcia; Xiaopin Ma; Alejandro Torrecillas; Qun Chen; Xiongwei Zhu; Edward Lesnefsky; Juan C Gomez-Fernandez; Bin Xu; Shijun Zhang
Journal:  J Med Chem       Date:  2018-01-05       Impact factor: 7.446

Review 8.  Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases.

Authors:  Hariharan Subramanian; Kshitij Gupta; Hydar Ali
Journal:  J Allergy Clin Immunol       Date:  2016-07-20       Impact factor: 10.793

9.  1H nuclear magnetic resonance determination of the membrane-bound conformation of senktide, a highly selective neurokinin B agonist.

Authors:  B Bersch; P Koehl; Y Nakatani; G Ourisson; A Milon
Journal:  J Biomol NMR       Date:  1993-07       Impact factor: 2.835

10.  Neuropeptides activate human mast cell degranulation and chemokine production.

Authors:  Marianna Kulka; Cecilia H Sheen; Brian P Tancowny; Leslie C Grammer; Robert P Schleimer
Journal:  Immunology       Date:  2007-10-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.